Phase II Study of Binimetinib in Children and Adults With NF1 Plexiform Neurofibromas
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Bruce Korf, MD, PhD
University of Alabama at Birmingham
Study Chair
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
22 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Children'S Hospital of Los Angeles
Los Angeles, California, United States
- University of California at Los Angeles
Los Angeles, California, United States
- Ucsf Benioff Children'S Hospital Oakland
Oakland, California, United States
- University of California, San Diego - Rady Children'S Hospital
San Diego, California, United States
- University of California, San Francisco
San Francisco, California, United States
- Children'S National Medical Center
Washington D.C., District of Columbia, United States
- Lurie Children'S Hospital of Chicago
Chicago, Illinois, United States
- University of Chicago
Chicago, Illinois, United States
- Indiana University
Indianapolis, Indiana, United States
- Johns Hopkins University
Baltimore, Maryland, United States
- National Institute of Health - National Cancer Institute
Bethesda, Maryland, United States
- Boston Children'S Hospital / Dana Farber Cancer Institute / Massachusetts General Hospital
Boston, Massachusetts, United States
- Washington University School of Medicine
St Louis, Missouri, United States
- New York University Medical Center
New York, New York, United States
- Cinncinnati Children'S Hospital Medical Center
Cincinnati, Ohio, United States
- Nationwide Children'S Hospital
Columbus, Ohio, United States
- Ohio State University
Columbus, Ohio, United States
- Oregon Health and Science University Hospital
Portland, Oregon, United States
- Children'S Hospital of Philadelphia
Philadelphia, Pennsylvania, United States
- University of Utah
Salt Lake City, Utah, United States
- University of Washington - Seattle Children'S Hospital
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 28 Nov 2017
- Primary completion
- 17 Apr 2024
- Completion
- 17 Apr 2024
- Last update posted
- 2 May 2025
- Registered enrollment
- 45
- Registry id
- NCT03231306
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.